Extracorporeal photopheresis (ECP) is one of the most used and established therapies for
steroid‐refractory graft‐vs‐host disease (GvHD), with a good effect to side effect profile. In …

Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

Autologous unstimulated leukapheresis product serves as starting material for a variety of
innovative cell therapy products, including chimeric antigen receptor (CAR)‐modified T …

Recipients of solid organ transplantation (SOT) rely on life-long immunosuppression (IS),
which is associated with significant side effects. Extracorporeal photochemotherapy (ECP) is …

Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative option for
many disease states. Despite significant improvements in strategies used to prevent and …

Background Extracorporeal photopheresis (ECP) is an effective treatment for graft‐vs‐host‐
disease (GvHD). Photopheresis can be performed in offline or inline method. The first uses a …

In adults, extracorporeal photopheresis (ECP) is widely utilized for a variety of indications,
most commonly cutaneous T‐cell lymphoma, acute or chronic graft‐versus‐host disease …

Hematopoietic stem cell donation is a method used to treat both blood-related and non-
blood-related malignancies. Graft-versus-host disease is a potentially life-threatening …

Graft-versus-host disease (GVHD) is a major cause of mortality and morbidity following
allogeneic hematopoietic stem cell transplantation. Extracorporeal photopheresis (ECP) …

Background Extracorporeal photopheresis (ECP) induces immunological changes that lead
to a reduced risk of transplant rejection. The aim of the present study was to determine …